Skip to main content
. 2020 Feb 27;19(4):3031–3041. doi: 10.3892/etm.2020.8564

Figure 4.

Figure 4

Efficacy endpoints of NSAIDs in ankylosing spondylitis. MDs among NSAIDs and placebo for (A) pain score and (B) patient's global assessment of disease activity. A negative MD value indicates a benefit from therapy. MD, mean difference; NSAIDs, non-steroidal anti-inflammatory drugs.